These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 5357076)

  • 1. Effects of sotalol and propranolol administered orally in man.
    Svedmyr N; Jakobsson B; Malmberg R
    Eur J Pharmacol; 1969 Oct; 8(1):79-82. PubMed ID: 5357076
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of some cardiovascular properties of propranolol, MJ 1999 and quinidine in relation to their effects in hypertensive animals.
    Farmer JB; Levy GP
    Br J Pharmacol; 1968 Sep; 34(1):116-26. PubMed ID: 5676002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative blocking effectiveness of propranolol and of practalol [4-(2-hydroxy-3-isopropylaminopropoxy) acetanilide] on isoprenaline in beta-1 receptor mediated calorigenesis.
    Arnold A; McAuliff JP
    J Pharm Pharmacol; 1969 Sep; 21(9):624-5. PubMed ID: 4390346
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of ICI 50172, propranolol, pronethalol and MJ 1999 on beta-receptors.
    Wale J; Pun LQ; Rand MJ
    Eur J Pharmacol; 1969 Oct; 8(1):25-35. PubMed ID: 4391044
    [No Abstract]   [Full Text] [Related]  

  • 5. [Analysis of cardiac beta-receptors. Studies by means of dose-effect-curves of isoprenaline, propranolol and KL 255].
    Holtermann W; Lochner W
    Arzneimittelforschung; 1970 Jan; 20(1):8-12. PubMed ID: 4392501
    [No Abstract]   [Full Text] [Related]  

  • 6. [Changes of heart volume and of various important spiroergometric parameters following receptor blockade].
    König K; Gebhardt W; Ullmann HW; Reindell H
    Z Kreislaufforsch; 1968 May; 57(5):415-29. PubMed ID: 5678692
    [No Abstract]   [Full Text] [Related]  

  • 7. Blockade of cardiac effects of isoproterenol by the stereoisomers of sotalol.
    Somani P; Bachand T
    Eur J Pharmacol; 1969 Sep; 7(3):239-47. PubMed ID: 4390869
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of the effects of propranolol and MJ 1999 on cardiac beta-adrenoceptors in man.
    Kofi Ekue JM; Lowe DC; Shanks RG
    Br J Pharmacol; 1970 May; 38(3):546-53. PubMed ID: 4392540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of some cardiovascular effects of sotalol (MJ 1999) and propranolol.
    Aberg G; Dzedin T; Lundholm L; Olsson L; Svedmyr N
    Life Sci; 1969 Apr; 8(7):353-65. PubMed ID: 5769443
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes in the mechanogram and other circulatory parameters induced by isoprenaline and adrenaline under the effect of verapamil, quinidine and adrenergic substances].
    Haas H
    Arzneimittelforschung; 1970 Apr; 20(4):501-9. PubMed ID: 5467814
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative beta-blocking activities and effects on sodium excretion of sotalol and propranolol.
    Rice AJ; Ferguson RK; Delle M; Wilson WR
    Clin Pharmacol Ther; 1970; 11(4):567-73. PubMed ID: 4393354
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of relative inotropic and chronotropic effects of propranolol, practolol, and sotalol.
    Goldstein RE; Hall CA; Epstein SE
    Chest; 1973 Nov; 64(5):619-27. PubMed ID: 4147980
    [No Abstract]   [Full Text] [Related]  

  • 13. Propranolol and sotalol as antagonists of isoproterenol-enhanced physiologic tremor.
    Pickles H; Perucca E; Fish A; Richens A
    Clin Pharmacol Ther; 1981 Sep; 30(3):303-10. PubMed ID: 6115732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-blockade and blood-levels after low-dose oral propranolol: The hepatic "first-pass" threshold revisited.
    Davies R; Pickering TG; Morganti A; Bianchetti G; Morselli PL; Romankiewicz J; Laragh JH
    Lancet; 1978 Feb; 1(8061):407-10. PubMed ID: 75440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular effects of acebutolol (M & B 17803A), in exercising man; a comparative study with practolol and propranolol.
    Coleman AJ; Leary WP
    Curr Ther Res Clin Exp; 1972 Oct; 14(10):673-8. PubMed ID: 4404477
    [No Abstract]   [Full Text] [Related]  

  • 16. Systemic and coronary hemodynamic effects of pronethalol practolol, sotalol and D-propranolol.
    Rowe GG; Berndt TB; O'Brien GS; Afonso S
    Arch Int Pharmacodyn Ther; 1972 Nov; 200(1):5-24. PubMed ID: 4404935
    [No Abstract]   [Full Text] [Related]  

  • 17. Circulatory effects of propranolol in children with Fallot's tetralogy. Observations with isoproterenol infusion, exercise and crying.
    Shah PM; Kidd L
    Am J Cardiol; 1967 May; 19(5):653-7. PubMed ID: 6024709
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of propranolol on haemodynamic parameters and myocardial blood flow during acute anoxia in dogs.
    Skolasińska K; Sandor P; Tomaszewicz H; Zurowski S
    Acta Physiol Pol; 1973; 24(1):159-63. PubMed ID: 4716338
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular effects of prinodolol (LB-46), a potent beta-adrenergic receptor antagonist.
    Levy JV
    J Clin Pharmacol New Drugs; 1971; 11(4):249-60. PubMed ID: 4397374
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of triiodothyronine on hemodynamic responses to epinephrine and norepinephrine in man.
    Aoki VS; Wilson WR; Theilen EO; Lukensmeyer WW; Leaverton PE
    J Pharmacol Exp Ther; 1967 Jul; 157(1):62-8. PubMed ID: 6029492
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.